Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Table. 6.

Effect of prunetin on TBARS and HP activity in the kidney tissues of control and experimental rats

Groups TBARS HP
Control 1.40 ± 0.10 55.01 ± 4.18
STZ (diabetic control) 2.64 ± 0.20* 124.06 ± 9.49*
PRU 80 mg/kg 1.44 ± 0.11 53.21 ± 4.05
STZ+PRU 20 mg/kg 2.01 ± 0.15# 108.05 ± 8.27#
STZ+PRU 40 mg/kg 1.86 ± 0.14# 89.12 ± 6.78#
STZ+PRU 80 mg/kg 1.55 ± 0.11## 60.02 ± 4.56##

Values are expressed as means ± SD (n=6 rats for each group; test were performed in triplicate). *p<0.05 versus Control group; #p<0.05, ##p<0.01 versus STZ (diabetic control group).

Biomolecules & Therapeutics 2023;31:619~628 https://doi.org/10.4062/biomolther.2023.068
© Biomolecules & Therapeutics